» Articles » PMID: 10480432

Ectopic Overexpression of C-mpl by Retroviral-mediated Gene Transfer Suppressed Megakaryopoiesis but Enhanced Erythropoiesis in Mice

Overview
Journal Exp Hematol
Specialty Hematology
Date 1999 Sep 10
PMID 10480432
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In this report, we tested whether ectopic overexpression of a cell surface receptor cDNA could be used to explore the physiological roles of that receptor. We generated c-mpl overexpressing animals by reconstituting mice with retroviral vector-transduced bone marrow (BM) cells. We observed that platelet counts in the c-mpl overexpressing mice failed to recover to normal levels and remained at <200 x 10(6)/mL post-transplantation, while platelet numbers in the control mice returned to > 800 x 10(6)/mL by 4 weeks post-transplantation. However, platelet counts in the c-mpl overexpressing mice could be stimulated to normal levels after administration of rhMGDF. No significant changes in peripheral leukocyte counts were observed, although the number of CFU-E, GM-CFC, and CFC-multi were reduced two- to threefold in the BM of the c-mpl overexpressing mice. In addition, enhanced erythropoiesis was observed in the c-mpl overexpressing mice. The mpl receptors on erythroid cells were functional as demonstrated by tyrosine-phosphorylation of mpl receptor on RBC and by in vitro erythroid colony-formation in response to MGDF stimulation, respectively. These results suggested that ectopically expressed mpl receptors competed for ligand in vivo leading to an insufficient amount of circulating thrombopoietin (Tpo) for the development of megakaryocytic lineage. These results further suggest that, in addition to sequestering circulating Tpo, overexpression of the mpl receptor on erythroid progenitors may directly contribute to enhanced erythropoiesis in vivo. Our studies demonstrate that ectopic overexpression of a receptor by retroviral-mediated gene transfer provides an approach to explore the biological roles of novel receptors.

Citing Articles

Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance.

Kohlscheen S, Wintterle S, Schwarzer A, Kamp C, Brugman M, Breuer D PLoS One. 2015; 10(7):e0131866.

PMID: 26147434 PMC: 4493002. DOI: 10.1371/journal.pone.0131866.


Novel pathways to erythropoiesis induced by dimerization of intracellular C-Mpl in human hematopoietic progenitors.

Parekh C, Sahaghian A, Kim W, Scholes J, Ge S, Zhu Y Stem Cells. 2012; 30(4):697-708.

PMID: 22290824 PMC: 3973153. DOI: 10.1002/stem.1046.


Mouse models of diseases of megakaryocyte and platelet homeostasis.

Carmichael C, Alexander W Mamm Genome. 2011; 22(7-8):449-65.

PMID: 21667128 DOI: 10.1007/s00335-011-9336-4.


Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia.

Wicke D, Meyer J, Buesche G, Heckl D, Kreipe H, Li Z Mol Ther. 2009; 18(2):343-52.

PMID: 19844195 PMC: 2839299. DOI: 10.1038/mt.2009.233.


Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.

Lannutti B, Epp A, Roy J, Chen J, Josephson N Blood. 2008; 113(8):1778-85.

PMID: 18796624 PMC: 2647669. DOI: 10.1182/blood-2007-11-124859.